Yatharth Hospital Receives CCI Approval for ₹3,150 Crore Preferential Issue; Shares Gain

Mumbai, November 12: Yatharth Hospital & Trauma Care Services Limited announced that it has received approval from the Competition Commission of India (CCI) for its proposed preferential issue worth ₹3,150 crore. The approval relates to the proposed issuance and allotment of securities to Yuzusoff Limited, an entity incorporated under the laws of Cyprus. The company disclosed the development in a regulatory filing dated November 12, 2026. According to the announcement, the CCI granted approval through a letter dated November 10, 2026. The proposed transaction remains subject to other applicable regulatory and statutory requirements.

Yatharth Hospital Secures CCI Approval for Proposed Preferential Issue

Yatharth Hospital had earlier informed stock exchanges about the proposed preferential issue through a communication dated September 22, 2026. Under the arrangement, the company plans to issue and allot securities on a private placement basis to Yuzusoff Limited for an aggregate cash consideration of ₹31,500 million, equivalent to ₹3,150 crore. Following the proposed allotment, the investor is expected to hold approximately 24.87% of Yatharth Hospital’s post-issue share capital on a fully diluted basis. The company confirmed that the Competition Commission of India has approved the proposed transaction. However, the CCI clearance does not mean that the preferential allotment has been completed. Further regulatory and statutory conditions must be fulfilled before the proposed investment can proceed. The transaction, once completed, would bring a substantial new shareholder into the hospital operator. The preferential issue would also raise capital for the company, although the latest disclosure does not specify the intended utilisation of the proceeds. Yatharth Hospital has not announced a revised completion timeline in the latest filing.

Stock Market Snapshot

Yatharth Hospital share price traded higher during the morning session on November 12, 2026, following the regulatory approval announcement. Based on the supplied intraday chart, the stock was trading at approximately ₹1,056.50 around 10:34 AM IST, compared with a previous closing reference level near ₹1,042.80. This indicates an approximate increase of ₹13.70, or 1.31%. The stock opened near ₹1,038 before moving sharply higher during the initial minutes of trading, climbing above ₹1,050. After experiencing some fluctuations around ₹1,045 during the early session, the share price gradually recovered and moved towards ₹1,055. The stock subsequently touched approximately ₹1,059 shortly after 10:00 AM IST before easing slightly. It continued trading above the previous closing reference level towards the end of the supplied chart.

About Yatharth Hospital & Trauma Care Services

Yatharth Hospital & Trauma Care Services Limited is an Indian hospital operator providing healthcare services across multiple medical specialties. The company operates a network of hospitals in North India, with facilities in Uttar Pradesh, Delhi, Haryana and Madhya Pradesh. Its healthcare services cover areas such as general medicine, surgery, critical care, trauma care and specialised treatments. Yatharth Hospital focuses on providing secondary and tertiary healthcare services through its hospital network. The company’s shares are listed on the BSE under code 543950 and on the National Stock Exchange under the symbol YATHARTH.

Conclusion

Yatharth Hospital has received CCI approval for its proposed ₹3,150 crore preferential issue to Yuzusoff Limited, marking a regulatory milestone for the planned investment. The proposed transaction would give the investor a 24.87% stake in the company’s post-issue share capital on a fully diluted basis. Although the competition regulator has cleared the transaction, completion remains dependent on fulfilling other applicable regulatory and statutory requirements. The development brings Yatharth Hospital closer to its proposed capital-raising transaction, with investors likely to monitor further announcements regarding the allotment and completion of the investment.

Source:

• https://www.nseindia.com/get-quote/equity/YATHARTH/Yatharth-Hospital-&-Trauma-Care-Services-Limited